MAPT and Alzheimer disease: The study by Dang et al. [122] emphasizes the significant correlation between tau accumulation and cognitive decline, as well as neuropsychiatric symptoms, showcasing its diagnostic superiority over Aβ for distinguishing AD patients from cognitively normal controls.